Broker Forecast - HSBC issues a broker note on GlaxoSmithKline PLC

Writer, Stock Market Wire
Thursday, February 7, 2019 - 10:50

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1860p (from 1820p).

Broker Forecasts data provided by www.sharesmagazine.co.uk


Related content

Smiths Group and Pharmaceutical Stocks

“Having enjoyed a strong finish on Thursday amid a big slide in sterling, the FTSE 100 is modestly lower on Friday as news that the...

Fri, 22/03/2019 - 10:04


Kingfisher in a fix as DIY expert looks for a new boss

Kingfisher’s failure to increase its dividend for a tenth year in a row – and join an elite club of just 26 current FTSE...

Wed, 20/03/2019 - 15:47


Broker Forecast - Shore Capital issues a broker note on GlaxoSmithKline PLC

Shore Capital today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to hold (from buy).

Broker Forecasts data provided by www.sharesmagazine.co.uk...

Fri, 08/03/2019 - 08:50


GlaxoSmithKline's JV ViiV Healthcare says trials for injectable HIV treatment met objectives

GlaxoSmithKline said Friday its ViiV Healthcare joint venture with Pfizer had said two clinical trials of a an injectable two-drug regime for the treatment of...

Fri, 08/03/2019 - 07:31


How I invest: hoping for good returns in retirement

Peter from Bromley has been investing in the stock market since the 1980s when he bought shares in British Gas. Now aged 71, the former...

Thu, 07/03/2019 - 00:00